PubMed (GeneRIF) for id: 9988

Year	Number of Results
2003	1
2004	1
2007	2
2008	1
2010	1
2011	1
2012	2
2013	2
2015	2
2017	1
2018	2
2019	2
2020	2
2021	1
2024	0

1

Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α.

Li J, Shi K, Xu T, Hu J, Li T, Li G, Chen K, Li D, Inoue K, Sui G. Li J, et al. Int J Oncol. 2021 Jan;58(1):20-32. doi: 10.3892/ijo.2020.5146. Epub 2020 Nov 10. Int J Oncol. 2021. PMID: 33367929 Free PMC article.

2

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53.

Fry EA, Niehans GE, Kratzke RA, Kai F, Inoue K. Fry EA, et al. Int J Mol Sci. 2020 Oct 27;21(21):7971. doi: 10.3390/ijms21217971. Int J Mol Sci. 2020. PMID: 33120969 Free PMC article.

3

c-MYB and DMTF1 in Cancer.

Fry EA, Inoue K. Fry EA, et al. Cancer Invest. 2019;37(1):46-65. doi: 10.1080/07357907.2018.1550090. Epub 2019 Jan 2. Cancer Invest. 2019. PMID: 30599775 Free PMC article. Review.

4

miR‑675 promotes colorectal cancer cell growth dependent on tumor suppressor DMTF1.

Yang X, Lou Y, Wang M, Liu C, Liu Y, Huang W. Yang X, et al. Mol Med Rep. 2019 Mar;19(3):1481-1490. doi: 10.3892/mmr.2018.9780. Epub 2018 Dec 20. Mol Med Rep. 2019. PMID: 30592263 Free PMC article.

5

Cisplatin sensitivity in breast cancer cells is associated with particular DMTF1 splice variant expression.

Niklaus NJ, Humbert M, Tschan MP. Niklaus NJ, et al. Biochem Biophys Res Commun. 2018 Sep 18;503(4):2800-2806. doi: 10.1016/j.bbrc.2018.08.042. Epub 2018 Aug 9. Biochem Biophys Res Commun. 2018. PMID: 30100063

6

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.

Tian N, Li J, Shi J, Sui G. Tian N, et al. Int J Mol Sci. 2017 Mar 2;18(3):191. doi: 10.3390/ijms18030191. Int J Mol Sci. 2017. PMID: 28257090 Free PMC article. Review.

7

Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.

Tschan MP, Federzoni EA, Haimovici A, Britschgi C, Moser BA, Jin J, Reddy VA, Sheeter DA, Fischer KM, Sun P, Torbett BE. Tschan MP, et al. Biochim Biophys Acta. 2015 Sep;1849(9):1198-208. doi: 10.1016/j.bbagrm.2015.07.009. Epub 2015 Jul 15. Biochim Biophys Acta. 2015. PMID: 26187004 Free PMC article.

8

MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.

Peng Y, Dong W, Lin TX, Zhong GZ, Liao B, Wang B, Gu P, Huang L, Xie Y, Lu FD, Chen X, Xie WB, He W, Wu SX, Huang J. Peng Y, et al. Oncotarget. 2015 Jun 30;6(18):16043-58. doi: 10.18632/oncotarget.3755. Oncotarget. 2015. PMID: 25965824 Free PMC article.

9

Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.

Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Zhu S, et al. Am J Pathol. 2013 Oct;183(4):1339-1350. doi: 10.1016/j.ajpath.2013.06.027. Epub 2013 Aug 11. Am J Pathol. 2013. PMID: 23938323 Free PMC article.

10

Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.

Maglic D, Zhu S, Fry EA, Taneja P, Kai F, Kendig RD, Sugiyama T, Miller LD, Willingham MC, Inoue K. Maglic D, et al. Oncogene. 2013 Aug 29;32(35):4120-9. doi: 10.1038/onc.2012.423. Epub 2012 Oct 8. Oncogene. 2013. PMID: 23045280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year